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the choice of delivery method for pregnant women with
coronavirus disease 2019 (COVID-19). Although we did not
mean that vaginal delivery should be overencouraged, we
agree with the opinion that obstetricians should maintain
their obstetrical indications. However, a high incidence of
cesarean deliveries was mentioned by Dr Carosso. It might
result from concerns that SARS-CoV-2 exists in the vagina. It
was a reasonable suspicion because SARS-CoV-2 had been
identified in anal swabs, urine, and tears in an earlier study.1
We did test samples from the vagina; however, no samples
were positive. Therefore, SARS-CoV-2 infection should not
be considered as a direct indication for cesarean delivery at
present. Our results may provide evidence for obstetricians to
choose the delivery method on the basis of obstetrical in-
dications for pregnant women with COVID-19.
In addition to choosing the appropriate delivery method, it
is equally important to find out possible transmission routes
and take targeted measures, as potential vertical transmission
was reported after both vaginal delivery and cesarean
delivery.2,3
We agree with Dr Carosso’s concerns about the anorectum
as a potential transmission route during vaginal delivery.
Based on the positive anal swab cases in our study, we think
that we should pay full attention to the preventive measures
during vaginal delivery. Because of the low positive rate of
anal swabs in detecting SARS-CoV-2, results have been
confusing. We are responsible for this result as all the samples
were double tested and checked in 2 different labs with full
qualification certification. As patients with COVID-19 were
all in a separate special ward, the sample size of our research
was a large one under the situation of the COVID-19
pandemic. The time between onset of symptoms and sam-
ple collection varied for the same reason. A small portion of
patients did not have positive oropharyngeal swabs. The
reasons had been listed in our original published article. In
addition, all patients’ symptoms, including intestinal, were
collected but not mentioned because of the length of limi-
tation of the research letter.
Vaginal delivery is a very complex physiological process,
and vertical transmission of SARS-CoV-2 from the mother to
the offspring via the placenta, birth canal, or intestinal tract is
poorly understood at this moment. To obtain more evidence
of transmission route of SARS-CoV-2, we need to involve as
many pregnant women with COVID-19 as we can and test all
samples including anal swabs. -
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A call for precision in coronavirus disease case
reporting: a crucial step more important now
than ever
TO THE EDITORS: With great interest, I read the article of
Lokken et al1 who asserted in their Condensation and
Conclusions sections that “severe COVID-19 occurred in
15% of pregnant patients,” a very novel finding. However, in
further reviewing their methodology, it is clear that severe
coronavirus disease 2019 (COVID-19) cases (n¼6) came
from a pool of pregnant patients among hospitals which
“have 34,000 deliveries annually,” abstracted over 87 days.
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Thus, the expected denominator would be something in the
order of 8104 deliveries in this pool during the study
period. This denominator would yield a rate of
severe COVID-19 of approximately 0.07% among pregnant
patients, not 15%.
In these days of rapid learning and a near tsunami of
COVID-19 updates to our clinical and epidemiologic
knowledge base, I believe it is important that all authors
strive to be precise and factual in these important com-
munications. Lokken et al1 detailed the specifics through
their abstract and manuscript in both their Methods and
Results sections. However, they have done a disservice to
busy clinicians and readers of American Journal of Obstetrics
and Gynecology when they summarized incorrectly in their
conclusion that “Nearly 15% of pregnant patients developed
severe COVID-19.” We must all strive to mitigate, not
exacerbate, the many unintended consequences of this
pandemic. -
Wendy V. Norman, MD, MHSc
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REPLY
We thank Dr Norman for the call for precision in reporting
results, particularly during the coronavirus disease 2019
(COVID-19) pandemic1; we could not agree more. Pregnant
women and clinicians need such data to make informed and
evidence-based decisions during this stressful time. The
objective of our case series of 46 pregnant patients with
confirmed severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infections was to report the clinical outcomes
of COVID-19 among these patients.2 Our aim was not to
provide population-health estimates on the rate of infection
or severe disease among all pregnant patients during this
time, as estimated by Dr Norman. Although a rigorous
assessment of the population-based risk in pregnancy is
important, a key estimate for obstetricians right now is the
likelihood that a patient infected with SARS-CoV-2 will
experience severe disease or adverse pregnancy outcomes. We
believe that our report stating that 15% of pregnant patients
with COVID-19 had severe disease is accurate (6 of 46 pa-
tients with COVID-19; 6 of 43 symptomatic patients). As
obstetricians, we aimed to understand the effect of COVID-
19 on our own patients to counsel them to the best of our
ability.
Our case series reported all known cases from 6 large
hospital systems contributing 40% of the annual deliveries
in Washington State. This was a key strength of our
manuscript because we captured confirmed infections in
pregnancy across all trimesters, independent of severity.
Our abstract and manuscript clearly reported outcomes on
46 pregnant women with SARS-CoV-2 infections with
study results targeted to these patients. We did not attempt
to make larger population-wide conclusions across Wash-
ington State. Although the rate of SARS-CoV-2 infections
and severe COVID-19 disease among all pregnant women
in Washington State is low, our case series indicates that we
cannot discount the potential for severe disease among
pregnant individuals who acquire SARS-CoV-2 infections.
In particular, we highlight factors that may increase the
risk of severe COVID-19 in pregnancy, such as obesity
and asthma, which may affect counseling or medical
management after SARS-CoV-2 diagnosis; these factors
deserve further study.
There are many ways to leverage data to estimate the effects
of a disease on individuals and on the population, each of
which is appropriate for different purposes and audiences.
For our manuscript, the goal was to provide obstetrical care
providers with key clinical insights into disease outcomes
among pregnancies affected by SARS-CoV-2 specifically to
urgently inform clinical care. -
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